The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis
- 31 March 2008
- journal article
- Published by Springer Nature in Oncogene
- Vol. 27 (31) , 4353-4362
- https://doi.org/10.1038/onc.2008.79
Abstract
The impact of oxidative stress in human cancer has been extensively studied. It is accepted that elevated reactive oxygen species (ROS) promote mutagenic DNA damage. Even with an extensive armament of cellular antioxidants and detoxification enzymes, alterations to DNA occur that initiate cellular transformation. Erythroid 2p45 (NF-E2)-related factor 2 (Nrf2) is a basic-region leucine zipper transcription factor that mediates the expression of key protective enzymes through the antioxidant-response element (ARE). By analysing 10 human prostate cancer microarray data sets, we have determined that Nrf2 and members of the glutathione-S-transferase (GST) mu family are extensively decreased in human prostate cancer. Using the TRAMP transgene and Rb and Nrf2 knockout murine models, we demonstrated that the loss of Nrf2 initiates a detrimental cascade of reduced GST expression, elevated ROS levels and ultimately DNA damage associated with tumorigenesis. Based on overwhelming data from clinical samples and the current functional analysis, we propose that the disruption of the Nrf2-antioxidant axis leads to increased oxidative stress and DNA damage in the initiation of cellular transformation in the prostate gland.Keywords
This publication has 47 references indexed in Scilit:
- Inflammation in prostate carcinogenesisNature Reviews Cancer, 2007
- Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-ImidazolidePublished by Elsevier ,2006
- Multiorgan Autoimmune Inflammation, Enhanced Lymphoproliferation, and Impaired Homeostasis of Reactive Oxygen Species in Mice Lacking the Antioxidant-Activated Transcription Factor Nrf2The American Journal of Pathology, 2006
- PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancer.Clinical Cancer Research, 2006
- Inhibition of DNA Methyltransferase Activity Prevents Tumorigenesis in a Mouse Model of Prostate CancerCancer Research, 2006
- Nrf2 as a target for cancer chemopreventionMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2005
- Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in miceThe Journal of Experimental Medicine, 2005
- Chemoprevention through the Keap1–Nrf2 signaling pathway by phase 2 enzyme inducersMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2004
- Functional Characterization of Transcription Regulators That Interact with the Electrophile Response ElementBiochemical and Biophysical Research Communications, 2001
- Delineation of prognostic biomarkers in prostate cancerNature, 2001